Nephros, Inc. announced its entry into the Puerto Rican market to provide water filtration solutions for medical and commercial applications. The company targets high-need applications including ice machines, drinking fountains, bottle fillers, and sterile processing environments in a region it describes as underserved by premium filtration providers.
The company estimates the Puerto Rican market represents a $10 million opportunity across multiple sectors. Healthcare represents the largest segment at $3 million, followed by foodservice at $3 million, hotels at $1 million, other hospitality at $1 million, and service contracts and replacements at $1 million. Nephros believes its infection-control filtration solutions address unmet needs in Puerto Rico, where waterborne pathogen risks and infrastructure-driven water quality challenges create demand for point-of-use purification.
Robert Banks, President and CEO of Nephros, stated the company views Puerto Rico as a massively underserved market for reliable, high-quality filtration, particularly in environments where bacteria and harmful contaminants in water can have serious consequences. The company's entry into Puerto Rico represents a natural extension of its core strategy to leverage technology and execution to meet critical water safety needs.
Nephros plans to differentiate itself through rapid response and fulfillment from a dedicated inventory network, on-site installation and scheduled filter replacements, and customer support and technical documentation in Spanish. The company's point-of-use filtration targets microbial control and regulated drinking water contaminants such as lead and PFAS. This localized approach aims to ensure compliance, reliability, and ease of use for customers across the island.
The expansion aligns with Nephros' broader growth strategy to move beyond traditional patient care into adjacent markets supporting water safety within hospitality and foodservice. Banks expressed inspiration from the market's momentum and cultural pride, noting that small, agile companies with appropriate technology and teams can create meaningful impact in complex, fragmented markets. For more information about Nephros, please visit https://nephros.com.
The company's forward-looking statements acknowledge various risks and uncertainties, including dependence on third-party manufacturers, distributors and researchers, changes in competitive conditions, and regulatory reforms. These risks are detailed in Nephros' reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2024. The latest news and updates relating to Nephros are available in the company's newsroom at https://tinyurl.com/nephnewsroom.
